Funding Opportunities

• Novel Assays to Address Translational Gaps in Treatment Development (UG3/UH3 Clinical Trial Optional)
  (PAR-22-169)
  National Institute of Mental Health
  Application Receipt Date(s): January 12, 2023
• Building in vivo Preclinical Assays of Circuit Engagement for Application in Therapeutic Development (R01 Clinical Trial Not Allowed)
  (PAR-22-170)
  National Institute of Mental Health
  Application Receipt Date(s): September 7, 2025
• CCRP Initiative: Countermeasures Against Chemical Threats (CounterACT) Therapeutics Discovery and Early-Stage Development (UG3/UH3 Clinical Trial Not Allowed)
  (PAR-22-209)
  National Institute of Neurological Disorders and Stroke
  National Institute of Allergy and Infectious Diseases
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  National Institute on Drug Abuse
  National Institute of Environmental Health Sciences
  National Eye Institute
  Application Receipt Date(s): October 17, 2024
• Impact of the Microbiome-Gut-Brain Axis on Alzheimer's Disease and Alzheimer's Disease-Related Dementias (R01 Clinical Trial Not Allowed)
  (PAR-22-211)
  National Institute of Neurological Disorders and Stroke
  National Institute on Aging
  Application Receipt Date(s): October 5, 2022
• Complex Integrated Multi-Component Projects in Aging Research (U19 Clinical Trial Optional)
  (PAR-22-213)
  National Institute on Aging
  Application Receipt Date(s): September 25, 2025
• Claude D. Pepper Older Americans Independence Centers (P30 Clinical Trial Optional)
  (RFA-AG-23-017)
  National Institute on Aging
  Application Receipt Date(s): October 19, 2022
• NIA Research and Entrepreneurial Development Immersion (REDI): Entrepreneurial Small Business Transition Award (R43/R44 Clinical Trial Optional)
  (RFA-AG-23-029)
  National Institute on Aging
  Application Receipt Date(s): February 17, 2023
• NIA Research and Entrepreneurial Development Immersion (REDI): Entrepreneurial Small Business Transition Award (R41/R42 Clinical Trial Optional)
  (RFA-AG-23-030)
  National Institute on Aging
  Application Receipt Date(s): February 17, 2023
• HEAL Initiative: Rapidly Assessing the Public Health Impact of Emerging Opioid Threats (UG1 - Clinical Trial Not Allowed)
  (RFA-DA-23-045)
  National Institute on Drug Abuse
  National Institute on Alcohol Abuse and Alcoholism
  National Center for Complementary and Integrative Health
  Application Receipt Date(s): February 2, 2023
• HEAL Initiative: Research to Foster an Opioid Use Disorder Treatment System Patients Can Count On (RM1 - Clinical Trial Optional)
  (RFA-DA-23-046)
  National Institute on Drug Abuse
  National Institute on Alcohol Abuse and Alcoholism
  National Center for Complementary and Integrative Health
  Application Receipt Date(s): February 2, 2023
• New Epidemiological Cohort Study among Asian Americans, Native Hawaiians, and Pacific Islanders (AsA-NHPI): Clinical/Community Field Centers (UG3/UH3 - Clinical Trial Not Allowed)
  (RFA-HL-23-015)
  National Heart, Lung, and Blood Institute
  National Human Genome Research Institute
  National Institute of Neurological Disorders and Stroke
  National Institute on Minority Health and Health Disparities
  Application Receipt Date(s): October 13, 2022
• New Epidemiological Cohort Study among Asian Americans, Native Hawaiians, and Pacific Islanders (AsA-NHPI): Coordinating Center (U24 - Clinical Trial Not Allowed)
  (RFA-HL-23-016)
  National Heart, Lung, and Blood Institute
  National Human Genome Research Institute
  National Institute of Neurological Disorders and Stroke
  National Institute on Minority Health and Health Disparities
  Application Receipt Date(s): October 13, 2022
• Regenerative Medicine Innovation Project (RMIP) Investigator-Initiated Clinical Trials (UG3/UH3 Clinical Trial Required)
  (RFA-HL-23-017)
  National Heart, Lung, and Blood Institute
  National Institute on Aging
  National Institute of Allergy and Infectious Diseases
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  National Institute of Dental and Craniofacial Research
  National Institute of Diabetes and Digestive and Kidney Diseases
  National Eye Institute
  National Institute of Neurological Disorders and Stroke
  National Center for Advancing Translational Sciences
  National Center for Advancing Translational Sciences
  Application Receipt Date(s): October 6, 2022
• Regenerative Medicine Innovation Projects (RMIP) Investigator- Initiated Studies (Collaborative U01 Clinical Trial Not Allowed)
  (RFA-HL-23-019)
  National Heart, Lung, and Blood Institute
  National Institute on Aging
  National Institute of Allergy and Infectious Diseases
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  National Institute on Deafness and Other Communication Disorders
  National Institute of Dental and Craniofacial Research
  National Institute of Diabetes and Digestive and Kidney Diseases
  National Eye Institute
  National Institute of Neurological Disorders and Stroke
  National Center for Advancing Translational Sciences
  National Center for Advancing Translational Sciences
  Application Receipt Date(s): October 6, 2022
• Regenerative Medicine Innovation Projects (RMIP) Clinical Trial Planning Grant (R34 - Clinical Trials Not Allowed)
  (RFA-HL-23-020)
  National Heart, Lung, and Blood Institute
  National Institute on Aging
  National Institute of Allergy and Infectious Diseases
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  National Institute of Dental and Craniofacial Research
  National Institute of Diabetes and Digestive and Kidney Diseases
  National Eye Institute
  National Institute of Neurological Disorders and Stroke
  National Center for Advancing Translational Sciences
  National Center for Advancing Translational Sciences
  Application Receipt Date(s): October 6, 2022
• Extracellular RNA Sequencing Research Resource for the Accelerating Medicines Partnership Parkinsons Disease (AMPPD) (R24 - Clinical Trial Not Allowed)
  (RFA-NS-23-014)
  National Institute of Neurological Disorders and Stroke
  Application Receipt Date(s): September 19, 2022